{"version":"1.0","type":"link","title":"Real-world outcomes of encorafenib, cetuximab ± binimetinib for BRAF‑mutated metastatic colorectal cancer: the BEETS (JACCRO CC‑18) study.","author_name":"Kotani D 외","author_url":"https://prs-insight.online/author/Kotani%20D","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/104483","thumbnail_width":1200,"thumbnail_height":630}